Growth Metrics

Sol-Gel Technologies (SLGL) Shares Outstanding (2016 - 2025)

Sol-Gel Technologies (SLGL) reported Shares Outstanding of $2.8 million for Q4 2025, little changed year-over-year from $2.8 million in Q4 2024, and little changed on a QoQ basis from $2.8 million in Q4 2024.

Sol-Gel Technologies (SLGL) has 10 years of Shares Outstanding data on file, last reported at $2.8 million in Q4 2025.

  • Quarterly Shares Outstanding changed 0.01% year-over-year to $2.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.8 million (changed 0.01% YoY) and the FY2025 annual result came in at $2.8 million, changed 0.01% from the prior year.
  • Shares Outstanding held at $2.8 million in Q4 2025 per SLGL's latest filing, from $2.8 million in the prior quarter.
  • Across five years, Shares Outstanding topped out at $23.1 million in Q4 2021 and bottomed at $2.3 million in Q4 2022.
  • The 5-year median for Shares Outstanding is $2.8 million (2023), against an average of $6.8 million.
  • The widest annual swing landed in 2022, when Shares Outstanding slumped 90.0%; it then gained 20.44% in 2023.
  • Tracing SLGL's Shares Outstanding over 5 years: stood at $23.1 million in 2021, then tumbled by 90.0% to $2.3 million in 2022, then rose by 20.44% to $2.8 million in 2023, then gained by 0.01% to $2.8 million in 2024, then retreated by 0.01% to $2.8 million in 2025.
  • Per Business Quant, the three latest SLGL Shares Outstanding figures stand at $2.8 million (Q4 2025), $2.8 million (Q4 2024), and $2.8 million (Q4 2023).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - 5.21 Mn
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn -
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - 56.35 Mn
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - 91.57 Bn
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 254.16 Mn
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn 1.80 Mn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 133.44 Mn
10 Sol-Gel Technologies 205.76 Mn 194.73 Mn - 2.79 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 2.79 Mn
Dec 31, 2025 2.79 Mn
Dec 31, 2025 2.79 Mn
Dec 31, 2025 2.79 Mn
Dec 31, 2025 2.79 Mn
Dec 31, 2025 2.79 Mn
Dec 31, 2025 2.79 Mn
Dec 31, 2025 2.79 Mn
Dec 31, 2024 2.79 Mn
Dec 31, 2024 2.79 Mn
Dec 31, 2024 2.79 Mn
Dec 31, 2024 2.79 Mn
Dec 31, 2024 2.79 Mn
Dec 31, 2024 2.79 Mn
Dec 31, 2024 2.79 Mn
Dec 31, 2024 2.79 Mn
Dec 31, 2023 2.79 Mn
Dec 31, 2023 2.79 Mn
Dec 31, 2023 2.79 Mn
Dec 31, 2023 2.79 Mn
Dec 31, 2023 2.79 Mn
Dec 31, 2023 2.79 Mn
Dec 31, 2023 2.79 Mn
Dec 31, 2023 2.79 Mn
Dec 31, 2022 2.31 Mn
Dec 31, 2022 2.31 Mn
Dec 31, 2022 2.31 Mn
Dec 31, 2022 2.31 Mn
Dec 31, 2022 2.31 Mn
Dec 31, 2022 2.31 Mn
Dec 31, 2022 2.31 Mn
Dec 31, 2022 2.31 Mn
Dec 31, 2021 23.13 Mn
Dec 31, 2021 23.13 Mn
Dec 31, 2021 23.13 Mn
Dec 31, 2021 23.13 Mn
Dec 31, 2021 23.13 Mn
Dec 31, 2021 23.13 Mn
Dec 31, 2021 23.13 Mn
Dec 31, 2021 23.13 Mn
Dec 31, 2020 23.00 Mn
Dec 31, 2020 23.00 Mn
Dec 31, 2020 23.00 Mn
Dec 31, 2020 23.00 Mn
Dec 31, 2020 23.00 Mn
Dec 31, 2020 23.00 Mn
Dec 31, 2020 23.00 Mn
Dec 31, 2020 23.00 Mn
Dec 31, 2019 20.40 Mn
Dec 31, 2019 20.40 Mn
Dec 31, 2019 20.40 Mn
Dec 31, 2019 20.40 Mn
Dec 31, 2019 20.40 Mn
Dec 31, 2019 20.40 Mn
Dec 31, 2019 20.40 Mn
Dec 31, 2019 20.40 Mn
Dec 31, 2018 18.95 Mn
Dec 31, 2018 18.95 Mn
Dec 31, 2018 18.95 Mn
Dec 31, 2018 18.95 Mn
Dec 31, 2018 18.95 Mn
Dec 31, 2018 18.95 Mn
Dec 31, 2018 18.95 Mn
Dec 31, 2018 18.95 Mn
Dec 31, 2017 6.29 Mn
Dec 31, 2017 6.29 Mn
Dec 31, 2017 6.29 Mn
Dec 31, 2017 6.29 Mn
Dec 31, 2017 6.29 Mn
Dec 31, 2017 6.29 Mn
Dec 31, 2017 6.29 Mn
Dec 31, 2017 6.29 Mn
Dec 31, 2016 6.29 Mn
Dec 31, 2016 6.29 Mn
Dec 31, 2016 6.29 Mn
Dec 31, 2016 6.29 Mn
Dec 31, 2016 6.29 Mn
Dec 31, 2016 6.29 Mn
Dec 31, 2016 6.29 Mn
Dec 31, 2016 6.29 Mn